FDA inspection

Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd.: FDA inspection ending Dec 1, 2023

FDA inspection 1226825 · No Action Indicated (NAI) · Shiyan

Key facts

Inspection ID 1226825
Firm Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd.
FEI number 3012129618
Address Industrial Park Zhuxi County
City Shiyan
Country China
Fiscal year 2024
Inspection end date Dec 1, 2023
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections